4th Quarter - Report

BAXTER HEALTHCARE CORPORATION for BAXTER HEALTHCARE CORPORATION

Firm
Client
Income
—
Expenses
$460,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

HR3, Elijah E. Cummings Lower Drug Costs Now Act, all provisions. HR19 / S. 2164, Lower Costs, More Cures Act of 2021, all provisions. Legislation to incentivize new technology for innovation in home dialysis (no current bill number). S.2025, Patient Access to ESRD New Innovative Devices Act, all provisions.

LobbyistCovered position, as disclosed
CADE CLURMAN —
MARK COIN —
CHRISTOPHER LEIBUNDGUTH —
JACK MANIKO —
CHRISTOPHER NASO —
JOSEPH V SCHWAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); Treasury, Dept of

Bills named: H.R. 19 (117th), S. 2025 (117th), S. 2164 (117th), H.R. 3 (117th)

Budget/Appropriations BUD

Issues related to increasing funding for Strategic National Stockpile.

LobbyistCovered position, as disclosed
CHRISTOPHER LEIBUNDGUTH —
JACK MANIKO —
JOSEPH V SCHWAN —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Treasury, Dept of; Homeland Security, Dept of (DHS); SENATE

Homeland Security HOM

Issues related to allocation and access to Baxter products during the COVID-19 emergency declaration.

LobbyistCovered position, as disclosed
CADE CLURMAN —
MARK COIN —
CHRISTOPHER LEIBUNDGUTH —
JACK MANIKO —
JOSEPH V SCHWAN —

Contacted: Treasury, Dept of; HOUSE OF REPRESENTATIVES; SENATE; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

Taxation of multinational companies. Monitor tax reform proposal relating to corporate tax policies.

LobbyistCovered position, as disclosed
CADE CLURMAN —
JOSEPH V SCHWAN —

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; SENATE; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS)

Health Issues HCR

Issues relating to drug pricing, home dialysis expansion, ESRD reimbursement for Hemodialysis, 340B Drug pricing, device sterilization, MDUFA reauthorization.

LobbyistCovered position, as disclosed
CADE CLURMAN —
MARK COIN —
CHRISTOPHER LEIBUNDGUTH —
JACK MANIKO —
CHRISTOPHER NASO —
JOSEPH V SCHWAN —

Contacted: HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); SENATE; Treasury, Dept of

Veterans VET

Veterans patient quality improvement. FY2022 MilConVA appropriations.

LobbyistCovered position, as disclosed
CADE CLURMAN —
MARK COIN —
CHRISTOPHER NASO —

Contacted: HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); SENATE; Health & Human Services, Dept of (HHS); Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.